FDA accelerates complex generic drug approval process
Food and Drug Administration Commissioner Scott Gottlieb on Monday said the FDA is introducing new policies to streamline the approval process for complex generic drugs, making it easier to bring generic competition to the complex brand-name drug market.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10